Liver fibrosis progression in a cohort of young HIV and HIV/ HBV co-infected patients: A longitudinal study using non-invasive APRI and Fib-4 scores

Liver fibrosis progression in a cohort of young HIV and HIV/ HBV co-infected patients: A longitudinal study using non-invasive APRI and Fib-4 scores

BackgroundThe risk of liver fibrosis increases over time in HIV and HIV-HBV individuals even under antiretroviral treatment (ART), warranting a rigorous and periodic monitorization. Given the lower availability of transient elastography, we aimed to assess the longitudinal variation of two non-invas...

Full description

Bibliographic Details
Main Authors:	Diana Gabriela Iacob, Monica Luminos, Otilia Elisabeta Benea, Ana-Maria Tudor, Cristina Mihaela Olariu, Simona Alexandra Iacob, Simona Ruta
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Medicine
Subjects:	liver fibrosis APRI score Fib-4 score HIV HIV/HBV co-infection non-invasive score
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2022.888050/full

Similar Items

Diagnostic performance of APRI and FIB-4 for confirming cirrhosis in Indonesian HIV/HCV co-infected patients
by: Evy Yunihastuti, et al.
Published: (2020-05-01)

Relationship of FIB-4 index with transient elastography in chronic hepatitis C patients having APRI ≥ 0.5 - ≤2 in a resource-limited setting in Pakistan
by: Annum Ishtiaq, et al.
Published: (2020-01-01)

Assessment of Liver Dysfunction Using Combination Biomarkers in Children Living with HIV Infection
by: Shalini Yadav, et al.
Published: (2022-12-01)

Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown
by: Simona Alexandra Iacob, et al.
Published: (2022-03-01)

Intestinal Microbiota as a Host Defense Mechanism to Infectious Threats
by: Simona Iacob, et al.
Published: (2019-01-01)

Evaluation of hepatic fibrosis in HIV/HCV co-infected individuals in Yaoundé, Cameroon: usefulness of APRI score in resource-constrained settings
by: Rodolphe Dobseu, et al.
Published: (2020-10-01)

Eosinophilic Colitis and Clostridioides difficile Sepsis With Rapid Remission After Antimicrobial Treatment; A Rare Coincidence and Its Pathogenic Implications
by: Simona Alexandra Iacob, et al.
Published: (2020-07-01)

APRI and FIB-4 performance to assess liver fibrosis against predefined Fibroscan values in chronic hepatitis C virus infection
by: Sumit Rungta, et al.
Published: (2021-01-01)

Ibalizumab Targeting CD4 Receptors, An Emerging Molecule in HIV Therapy
by: Simona A. Iacob, et al.
Published: (2017-11-01)

Evaluation of FIB-4, NFS, APRI and Liver Function Tests as Predictors for SARS-CoV-2 Infection in the Elderly Population: A Matched Case-Control Analysis
by: Mirela Loredana Grigoras, et al.
Published: (2022-08-01)

Assessment of hepatic fibrosis with non-invasive indices in subjects with diabetes before and after liver transplantation
by: Valeria Grancini, et al.
Published: (2024-03-01)

The liver fibrosis index is superior to the APRI and FIB-4 for predicting liver fibrosis in chronic hepatitis B patients in China
by: Dedong Huang, et al.
Published: (2019-10-01)

Utility of FIB4-T as a Prognostic Factor for Hepatocellular Carcinoma
by: Kazuya Kariyama, et al.
Published: (2019-02-01)

FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran
by: Behnaz Amernia, et al.
Published: (2021-12-01)

Use of AST platelet ratio index (APRI Score) as an alternative to liver biopsy for treatment indication in chronic hepatitis C
by: Mônica Salum Valverde Borsoi Viana, et al.
Published: (2009-01-01)

FIB-4 and APRI for cirrhosis detection in a privately insured national cohort
by: Neehar D. Parikh, et al.
Published: (2024-01-01)

AST/ALT ratio, APRI, and FIB-4 compared to FibroScan for the assessment of liver fibrosis in patients with chronic hepatitis B in Bandar Abbas, Hormozgan, Iran
by: Seyed Hamid Moosavy, et al.
Published: (2023-05-01)

Uso do score APRI na avaliação de doença hepática, após início de terapia antirretroviral, em pacientes portadores do HIV co-infectados com HCV versus monoinfectados por HIV Evaluation of APRI score in liver disease following the introduction of antiretroviral therapy in HIV and HCV coinfected versus HIV monoinfected patients
by: Vicente Sperb Antonello, et al.
Published: (2010-12-01)

Improving the Adherence to Antiretroviral Therapy, a Difficult but Essential Task for a Successful HIV Treatment—Clinical Points of View and Practical Considerations
by: Simona A. Iacob, et al.
Published: (2017-11-01)

HIV-HBV Coinfection—Current Challenges for Virologic Monitoring
by: Simona Ruta, et al.
Published: (2023-04-01)

LIMFOM ASOCIAT INFECȚIEI HIV – SERIE DE DOUĂ CAZURI CLINICE
by: Liana-Cătălina Gavriliu, et al.
Published: (2016-09-01)

Characteristics of Tuberculous Meningitis in HIV-Positive Patients from Northeast Romania
by: Isabela Ioana Loghin, et al.
Published: (2023-11-01)

CORRELATION OF FIB-4 AND APRI SCORE WITH FIBRO SCAN SCORE TO PREDICT FIBROSIS IN OBESE TYPE-2 DIABETIC PATIENTS.
by: Amit Kumar Das, et al.
Published: (2023-12-01)

Impact of HIV-1 Infection on the Natural Progress of an Anti-HCV Positive Population in an Impoverished Village in China from 2009 to 2017
by: Xinjie Li, et al.
Published: (2022-07-01)

FIB-4 and APRI as Predictive Factors for Short- and Long-Term Survival in Patients with Transjugular Intrahepatic Portosystemic Stent Shunts
by: Simone Anna Keimburg, et al.
Published: (2022-04-01)

Diagnostic accuracy of predictive indexes of liver fibrosis in patients with chronic hepatitis C
by: I. V. Maev, et al.
Published: (2020-02-01)

Assessment of bronchiectasis in adult HIV/AIDS patients
by: Oxana Munteanu, et al.
Published: (2020-10-01)

SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus
by: Simona Iacob, et al.
Published: (2020-08-01)

Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis
by: Simona Iacob, et al.
Published: (2019-08-01)

Liver Function Tests and FIB-4 Score as Predictors of Severity in COVID-19 Patients from the South-West of Romania
by: Adina M. Kamal, et al.
Published: (2022-06-01)

Evaluation of long-term changes of aspartate—platelet ratio index, FIB4, and liver stiffness in chronic hepatitis C patients successfully treated by direct-acting antivirals
by: Nadia Abdel Ataay Abdelkader, et al.
Published: (2021-08-01)

Effectiveness, tolerability and safety of Direct Acting Antivirals in Mexican individuals with Hepatitis C virus genotype-1 and previous pegylated interferon and ribavirin therapy
by: Daniel Melendez-Mena, et al.
Published: (2021-09-01)

Performance of noninvasive seromarkers in predicting liver fibrosis among MAFLD patients with or without viral hepatitis
by: Chung‐Feng Huang, et al.
Published: (2024-04-01)

Relationship of serum adiponectin and resistin levels with the severity of liver fibrosis in patients with chronic hepatitis B
by: Čustović Nerma, et al.
Published: (2022-01-01)

Combination Of ALBI And APRI To Predict Post-Hepatectomy Liver Failure After Liver Resection For HBV-Related HCC Patients
by: Mai R, et al.
Published: (2019-10-01)

Trabecular bone scores in young HIV-infected men: a matched case-control study
by: Youn Jeong Kim, et al.
Published: (2020-02-01)

Model for End-Stage Liver Disease Correlates with Disease Relapse and Death of Patients with Merkel Cell Carcinoma
by: Thilo Gambichler, et al.
Published: (2023-06-01)

Aspartate Aminotransferase to Platelet Ratio Index Score in Correlation with Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio to Predict Hepatic Cirrhosis in Hepatitis C Patients
by: Jane Haryanto, et al.
Published: (2022-06-01)

Hepatoprotective and Antifibrotic Effects of Indonesian Propolis
by: Diding Heri Prasetyo, et al.
Published: (2019-12-01)

Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population
by: Rommel Zambrano-Huailla, et al.
Published: (2020-11-01)